Vaccine trial

Bharat Biotech announced efficacy analysis data from Phase-3 clinical trials of Covaxin, proved to be highly effective against severe cases of COVID-19

Sharvil Patel, MD, Cadila Healthcare said, "As the first-ever plasmid DNA vaccine for human use, ZyCoV-D has proven its safety and efficacy profile in our fight against Covid-19".

In a separate trial in Serbia, 29% of 150 participants were found to have zero antibodies against the virus even after three months. In addition, the average age of the people who participated in the Serbian study was higher than 65.

So far, the government has not given such protection from liability to any of the three vaccines currently approved for use in India - Covishield, Covaxin, or Sputnik V.

While non-NDA states are lagging behind vaccinating eligible population, they are demanding to open up the vaccines to all adults

The phase 3 trials involved 25,800 subjects. The trial, done in collaboration with ICMR, is the largest ever clinical trial done in India.

Chinese government mouthpiece Global Times has claimed that India wants to monopolize the vaccine market in South Asia and hence is influencing its neighbouring nations to reject the Chinese vaccine.

The volunteer from Bhopal in Madhya Pradesh had died 10 days after he had participated in the clinical trial for Covaxin

Yesterday, Akhilesh Yadav tried to create panic in the society by stating that he would get vaccinated only when his government will be formed after the next election.

PM Modi had also expressed his gratitude for health workers, doctors, sanitation workers and other frontline warriors, who had put their lives in risk in the most adverse of circumstances.